Professor of Medicine, Harvard Medical School,
Department of Medical Oncology, Dana-Farber Cancer Institute
Boston, MA
For dissecting the role of intratumor heterogeneity in breast cancer and metastatic disease to develop risk assessment and personalized cancer therapy models and for extensively characterizing the metastatic potential of polyclonal tumors compared to monoclonal tumors.
The AACR established this lectureship, which is generously supported by Aflac, Inc., to recognize outstanding science that has inspired, or has the potential to inspire, new perspectives on the etiology, diagnosis, treatment, or prevention of breast cancer. To learn more, please visit the press release.
View Dr. Polyak’s Fellows of the AACR Academy page.